List of Excipients in API selegiline
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing selegiline
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Bausch Health US LLC | ZELAPAR | selegiline hydrochloride | 0187-0453 | ASPARTAME | |
| Bausch Health US LLC | ZELAPAR | selegiline hydrochloride | 0187-0453 | CITRIC ACID MONOHYDRATE | |
| Bausch Health US LLC | ZELAPAR | selegiline hydrochloride | 0187-0453 | FERRIC OXIDE YELLOW | |
| Bausch Health US LLC | ZELAPAR | selegiline hydrochloride | 0187-0453 | GELATIN | |
| Bausch Health US LLC | ZELAPAR | selegiline hydrochloride | 0187-0453 | GLYCERIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing selegiline
Detailed excipient profiles for selegiline
Excipient focus: ALCOHOL
selegiline drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
selegiline drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
selegiline drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
selegiline drug variants containing ANHYDROUS CITRIC ACID
selegiline drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
selegiline drug variants containing ANHYDROUS LACTOSE
selegiline drug variants not containing ANHYDROUS LACTOSE
Excipient focus: ASPARTAME
selegiline drug variants containing ASPARTAME
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing ASPARTAME
Excipient focus: BUTYL ALCOHOL
selegiline drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
selegiline drug variants containing CELLULOSE, MICROCRYSTALLINE
selegiline drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| Chartwell RX LLC | selegiline hydrochloride | 62135-694 |
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
selegiline drug variants containing CITRIC ACID MONOHYDRATE
selegiline drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: FD&C BLUE NO. 1
selegiline drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C RED NO. 40
selegiline drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing FD&C RED NO. 40
Excipient focus: FERRIC OXIDE YELLOW
selegiline drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
selegiline drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
selegiline drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing GELATIN
Excipient focus: GLYCERIN
selegiline drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing GLYCERIN
Excipient focus: ISOPROPYL ALCOHOL
selegiline drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE
selegiline drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | selegiline hydrochloride | 68151-2649 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
selegiline drug variants containing LACTOSE MONOHYDRATE
selegiline drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
selegiline drug variants containing MAGNESIUM STEARATE
selegiline drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
selegiline drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Bausch Health US LLC | selegiline hydrochloride | 0187-0453 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
selegiline drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
selegiline drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: POTASSIUM HYDROXIDE
selegiline drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
selegiline drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Chartwell RX LLC | selegiline hydrochloride | 62135-694 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
selegiline drug variants containing POVIDONE K25
| Company | Ingredient | NDC |
|---|---|---|
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing POVIDONE K25
Excipient focus: PROPYLENE GLYCOL
selegiline drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
selegiline drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
selegiline drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Rising Pharma Holdings Inc | selegiline hydrochloride | 16571-659 |
| Proficient Rx LP | selegiline hydrochloride | 71205-888 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM HYDROXIDE
selegiline drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing SODIUM HYDROXIDE
Excipient focus: STARCH, CORN
selegiline drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | selegiline hydrochloride | 62135-694 |
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
selegiline drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| i3 Pharmaceuticals LLC | selegiline hydrochloride | 72319-006 |
| A2A Integrated Pharmaceuticals | selegiline hydrochloride | 73141-006 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing STEARIC ACID
Excipient focus: TALC
selegiline drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Chartwell RX LLC | selegiline hydrochloride | 62135-694 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
selegiline drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Marlex Pharmaceuticals Inc | selegiline hydrochloride | 10135-737 |
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| Novitium Pharma LLC | selegiline hydrochloride | 70954-504 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
selegiline drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | selegiline hydrochloride | 60505-0055 |
| >Company | >Ingredient | >NDC |
selegiline drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
